Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668953 | SCV000793637 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2017-08-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003403553 | SCV004122582 | uncertain significance | not specified | 2023-10-09 | criteria provided, single submitter | clinical testing | Variant summary: SGCA c.279_284delCACCCC (p.Thr94_Pro95del) results in an in-frame deletion that is predicted to remove 2 amino acids from the encoded protein. The variant was absent in 248896 control chromosomes. c.279_284delCACCCC has been reported at a homozygous state in at-least one individual affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (example, BorkluYucel_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 32140910). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Genetic Diseases Diagnostic Center, |
RCV000668953 | SCV000864402 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2018-12-18 | no assertion criteria provided | clinical testing |